58 results
10-K
2018 FY
EX-10.18
VTAK
Catheter Precision Inc.
15 Mar 19
Annual report
12:00am
on individualized and company-wide targets, subject to the terms and conditions of the Company’s bonus plan for similarly situated employees … (the “Plan”), which will be approved and distributed following your start date with the Company. Your aggregate annual bonus opportunity will be equal to up
8-K
VTAK
Catheter Precision Inc.
9 Dec 19
Departure of Directors or Certain Officers
4:22pm
(the “Committee”) of the Board of Directors of Ra Medical Systems, Inc. (the “Company”) approved the award of a cash retention bonus (the “Retention Bonus … ”) of $179,220 to Andrew Jackson, the Company’s Interim Chief Executive Officer and Chief Financial Officer. The Retention Bonus is payable in four (4) equal
8-K
VTAK
Catheter Precision Inc.
12 Mar 20
Ra Medical Systems Appoints Medtech Executive Will McGuire as CEO and Director
4:56pm
. Mr. McGuire’s annual base salary will be $500,000. Mr. McGuire will be eligible to cash bonuses to receive an aggregate annual bonus opportunity … of up to 100% of his annual base salary, subject to the terms and conditions of the Company’s bonus plan for executives. For 2020, his bonus
8-K
VTAK
Catheter Precision Inc.
31 Jan 19
Departure of Directors or Certain Officers
4:02pm
, Inc. (the “Company”) approved the following cash bonus payments for the 2018 fiscal year to certain employees of the Company, including the Company’s … named executive officers and chief financial officer. Bonus payments were based on the Committee’s evaluation of each executive’s performance
S-1
EX-10.15
VTAK
Catheter Precision Inc.
16 Jul 18
IPO registration
5:13pm
.
Annual Bonus.For the Company’s 2018 fiscal year, you will have the opportunity to earn a target annual cash bonus equal to 50% of your annual base … , as applicable, any such bonus will be subject to your continued employment through and until the date of payment. Your annual bonus opportunity
10-Q
EX-10.2
09pa ysn155dt
14 Nov 18
Quarterly report
12:00am
S-1
EX-10.12
cvfb6q628 2slded
16 Jul 18
IPO registration
5:13pm
S-1
EX-10.13
72mt16 6xhwloz1
16 Jul 18
IPO registration
5:13pm
S-1
EX-10.14
4t0ee5x4jszyh96ykvb
16 Jul 18
IPO registration
5:13pm
8-K
EX-10.1
0mw33
18 Apr 23
Ra Medical Announces Resignation of CEO
6:04pm
DEF 14A
cj8heyb0u
19 Apr 19
Definitive proxy
12:16pm
10-Q
EX-10.1
t0zf6swhe5l33s 03
14 Nov 18
Quarterly report
12:00am
S-1
EX-10.9
ks07hzldz 026
16 Jul 18
IPO registration
5:13pm
S-1
EX-10.10
whvcn98nh55p
16 Jul 18
IPO registration
5:13pm
S-1
EX-10.11
hbc2jmmxn4 mwx
16 Jul 18
IPO registration
5:13pm